IR-Med (IRME) Share-based Compensation (2021 - 2025)
IR-Med recorded quarterly Share-based Compensation of $87000.0 in Q2 2025, down 84.84% quarter-over-quarter from $574000.0 in Q1 2025, and down 13.0% year-over-year from $100000.0 in Q2 2024.
IR-Med's Share-based Compensation history runs 5 years deep, the most recent figure standing at $87000.0 for Q2 2025.
- In Q2 2025, Share-based Compensation fell 13.0% year-over-year to $87000.0; the TTM figure through Jun 2025 stood at $840000.0 (down 24.53% YoY), while the FY2024 annual figure was $485000.0, down 71.17% from the prior year.
- Share-based Compensation came in at $87000.0 for Q2 2025 at IR-Med, down from $574000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.1 million in Q4 2022 to a low of -$18000.0 in Q4 2024.
- A 5-year average of $304666.7 and a median of $187500.0 in 2021 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation surged 801.89% in 2023 and sank 104.25% in 2024, its largest moves.
- IR-Med's Share-based Compensation stood at $178000.0 in 2021, then soared by 520.22% to $1.1 million in 2022, then plunged by 61.59% to $424000.0 in 2023, then sank by 104.25% to -$18000.0 in 2024, then soared by 583.33% to $87000.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $87000.0, $574000.0, and -$18000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | IR-Med | - | - | - | 87,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 574,000.00 |
| Mar 31, 2025 | 574,000.00 |
| Dec 31, 2024 | -18,000.00 |
| Dec 31, 2024 | -18,000.00 |
| Sep 30, 2024 | 197,000.00 |
| Sep 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 206,000.00 |
| Mar 31, 2024 | 206,000.00 |
| Dec 31, 2023 | 424,000.00 |
| Dec 31, 2023 | 424,000.00 |
| Sep 30, 2023 | 383,000.00 |
| Sep 30, 2023 | 383,000.00 |
| Jun 30, 2023 | 397,000.00 |
| Jun 30, 2023 | 397,000.00 |
| Mar 31, 2023 | 478,000.00 |
| Mar 31, 2023 | 478,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 124,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Jun 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 49,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 178,000.00 |
| Dec 31, 2021 | 178,000.00 |
| Sep 30, 2021 | 94,000.00 |
| Sep 30, 2021 | 94,000.00 |
| Jun 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | 32,000.00 |
| Mar 31, 2021 | 32,000.00 |